Global Oncology Molecular Diagnostics Market Professional Survey Report 2016

May 2016 | 161 pages | ID: GBD6C260C01EN
QYResearch

Abstracts

This report

Mainly covers the following product types

• DNA
• RNA
• protein

The segment applications including

• Breast cancer
• Colorectal cancer
• Prostate cancer
• Other cancers

Segment regions including (the separated region report can also be offered)

• USA
• China
• Japan
• Germany
• Canada
• Russia
• UK
• India
• Brazil

The players list (Partly, Players you are interested in can also be added)

• Abbott Diagnostics
• Becton, Dickinson and Company
• QIAGEN
• Roche Diagnostics
• Agendia
• Angsana Molecular and Diagnostics
• Asuragen
• Autogenomics
• Beckman Coulter
• bioMerieux
• bioTheranostics (Formerly AviaraDx)
• Cangen Biotechnologies
• Cepheid
• Diagnocure
• Epigenomics
• Eragen
• EXACT Sciences
• Exiqon
• GeneNews
• Genera Biosystems
• Genomic Health
• Genomix Biotech
• Zhejiang Di'an Diagnostics Technology
• Guangzhou Kingmed
• BGI-Shenzhen

With no less than 15 top producers.

Data including (both global and regions): Market Size (both volume - Unit and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/Unit, Cost, Gross margin etc.

More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!

Contents

1 INDUSTRY OVERVIEW OF ONCOLOGY MOLECULAR DIAGNOSTICS

1.1 Definition and Specifications of Oncology Molecular Diagnostics
  1.1.1 Definition of Oncology Molecular Diagnostics
  1.1.2 Specifications of Oncology Molecular Diagnostics
1.2 Classification of Oncology Molecular Diagnostics
  1.2.1 DNA
  1.2.2 RNA
  1.2.3 protein
1.3 Applications of Oncology Molecular Diagnostics
  1.3.1 Breast cancer
  1.3.2 Colorectal cancer
  1.3.3 Prostate cancer
  1.3.4 Other cancers
1.4 Industry Chain Structure of Oncology Molecular Diagnostics
1.5 Industry Overview and Major Regions Status of Oncology Molecular Diagnostics
  1.5.1 Industry Overview of Oncology Molecular Diagnostics
  1.5.2 Global Major Regions Status of Oncology Molecular Diagnostics
1.6 Industry Policy Analysis of Oncology Molecular Diagnostics
1.7 Industry News Analysis of Oncology Molecular Diagnostics

2 MANUFACTURING COST STRUCTURE ANALYSIS OF ONCOLOGY MOLECULAR DIAGNOSTICS

2.1 Raw Material Suppliers and Price Analysis of Oncology Molecular Diagnostics
2.2 Equipment Suppliers and Price Analysis of Oncology Molecular Diagnostics
2.3 Labor Cost Analysis of Oncology Molecular Diagnostics
2.4 Other Costs Analysis of Oncology Molecular Diagnostics
2.5 Manufacturing Cost Structure Analysis of Oncology Molecular Diagnostics
2.6 Manufacturing Process Analysis of Oncology Molecular Diagnostics

3 TECHNICAL DATA AND MANUFACTURING PLANTS ANALYSIS OF ONCOLOGY MOLECULAR DIAGNOSTICS

3.1 Capacity and Commercial Production Date of Global Oncology Molecular Diagnostics Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Oncology Molecular Diagnostics Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Oncology Molecular Diagnostics Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Oncology Molecular Diagnostics Major Manufacturers in 2015

4 GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS OVERALL MARKET OVERVIEW

4.1 2011-2016E Overall Market Analysis
  4.2.1 2011-2015 Global Oncology Molecular Diagnostics Capacity and Growth Rate Analysis
  4.2.2 2015 Oncology Molecular Diagnostics Capacity Analysis (Company Segment)
4.3 Sales Analysis
  4.3.1 2011-2015 Global Oncology Molecular Diagnostics Sales and Growth Rate Analysis
  4.3.2 2015 Oncology Molecular Diagnostics Sales Analysis (Company Segment)
4.4 Sales Price Analysis
  4.4.1 2011-2015 Global Oncology Molecular Diagnostics Sales Price
  4.4.2 2015 Oncology Molecular Diagnostics Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
  4.5.1 2011-2015 Global Oncology Molecular Diagnostics Gross Margin
  4.5.2 2015 Oncology Molecular Diagnostics Gross Margin Analysis (Company Segment)

5 ONCOLOGY MOLECULAR DIAGNOSTICS REGIONAL MARKET ANALYSIS

5.1 USA Oncology Molecular Diagnostics Market Analysis
  5.1.1 USA Oncology Molecular Diagnostics Market Overview
  5.1.2 USA 2011-2016E Oncology Molecular Diagnostics Local Supply, Import, Export, Local Consumption Analysis
  5.1.3 USA 2011-2016E Oncology Molecular Diagnostics Sales Price Analysis
  5.1.4 USA 2015 Oncology Molecular Diagnostics Market Share Analysis
5.2 China Oncology Molecular Diagnostics Market Analysis
  5.2.1 China Oncology Molecular Diagnostics Market Overview
  5.2.2 China 2011-2016E Oncology Molecular Diagnostics Local Supply, Import, Export, Local Consumption Analysis
  5.2.3 China 2011-2016E Oncology Molecular Diagnostics Sales Price Analysis
  5.2.4 China 2015 Oncology Molecular Diagnostics Market Share Analysis
5.3 Japan Oncology Molecular Diagnostics Market Analysis
  5.3.1 Japan Oncology Molecular Diagnostics Market Overview
  5.3.2 Japan 2011-2016E Oncology Molecular Diagnostics Local Supply, Import, Export, Local Consumption Analysis
  5.3.3 Japan 2011-2016E Oncology Molecular Diagnostics Sales Price Analysis
  5.3.4 Japan 2015 Oncology Molecular Diagnostics Market Share Analysis
5.4 Germany Oncology Molecular Diagnostics Market Analysis
  5.4.1 Germany Oncology Molecular Diagnostics Market Overview
  5.4.2 Germany 2011-2016E Oncology Molecular Diagnostics Local Supply, Import, Export, Local Consumption Analysis
  5.4.3 Germany 2011-2016E Oncology Molecular Diagnostics Sales Price Analysis
  5.4.4 Germany 2015 Oncology Molecular Diagnostics Market Share Analysis
5.5 Canada Oncology Molecular Diagnostics Market Analysis
  5.5.1 Canada Oncology Molecular Diagnostics Market Overview
  5.5.2 Canada 2011-2016E Oncology Molecular Diagnostics Local Supply, Import, Export, Local Consumption Analysis
  5.5.3 Canada 2011-2016E Oncology Molecular Diagnostics Sales Price Analysis
  5.5.4 Canada 2015 Oncology Molecular Diagnostics Market Share Analysis
5.6 Russia Oncology Molecular Diagnostics Market Analysis
  5.6.1 Russia Oncology Molecular Diagnostics Market Overview
  5.6.2 Russia 2011-2016E Oncology Molecular Diagnostics Local Supply, Import, Export, Local Consumption Analysis
  5.6.3 Russia 2011-2016E Oncology Molecular Diagnostics Sales Price Analysis
  5.6.4 Russia 2015 Oncology Molecular Diagnostics Market Share Analysis
5.7 UK Oncology Molecular Diagnostics Market Analysis
  5.7.1 UK Oncology Molecular Diagnostics Market Overview
  5.7.2 UK 2011-2016E Oncology Molecular Diagnostics Local Supply, Import, Export, Local Consumption Analysis
  5.7.3 UK 2011-2016E Oncology Molecular Diagnostics Sales Price Analysis
  5.7.4 UK 2015 Oncology Molecular Diagnostics Market Share Analysis
5.8 India Oncology Molecular Diagnostics Market Analysis
  5.8.1 India Oncology Molecular Diagnostics Market Overview
  5.8.2 India 2011-2016E Oncology Molecular Diagnostics Local Supply, Import, Export, Local Consumption Analysis
  5.8.3 India 2011-2016E Oncology Molecular Diagnostics Sales Price Analysis
  5.8.4 India 2015 Oncology Molecular Diagnostics Market Share Analysis
5.9 Brazil Oncology Molecular Diagnostics Market Analysis
  5.9.1 Brazil Oncology Molecular Diagnostics Market Overview
  5.9.2 Brazil 2011-2016E Oncology Molecular Diagnostics Local Supply, Import, Export, Local Consumption Analysis
  5.9.3 Brazil 2011-2016E Oncology Molecular Diagnostics Sales Price Analysis
  5.9.4 Brazil 2015 Oncology Molecular Diagnostics Market Share Analysis

6 GLOBAL 2011-2016E ONCOLOGY MOLECULAR DIAGNOSTICS SEGMENT MARKET ANALYSIS (BY TYPE)

6.1 Global 2011-2016E Oncology Molecular Diagnostics Sales by Type
6.2 Different Types Oncology Molecular Diagnostics Product Interview Price Analysis
6.3 Different Types Oncology Molecular Diagnostics Product Driving Factors Analysis
  6.3.1 DNA Oncology Molecular Diagnostics Growth Driving Factor Analysis
  6.3.2 RNA Oncology Molecular Diagnostics Growth Driving Factor Analysis
  6.3.3 protein Oncology Molecular Diagnostics Growth Driving Factor Analysis

7 GLOBAL 2011-2016E ONCOLOGY MOLECULAR DIAGNOSTICS SEGMENT MARKET ANALYSIS (BY APPLICATION)

7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
  7.3.1 Breast cancer Oncology Molecular Diagnostics Growth Driving Factor Analysis
  7.3.2 Colorectal cancer Oncology Molecular Diagnostics Growth Driving Factor Analysis
  7.3.3 Prostate cancer Oncology Molecular Diagnostics Growth Driving Factor Analysis
  7.3.4 Other cancers Oncology Molecular Diagnostics Growth Driving Factor Analysis

8 MAJOR MANUFACTURERS ANALYSIS OF ONCOLOGY MOLECULAR DIAGNOSTICS

8.1 Abbott Diagnostics
  8.1.1 Company Profile
  8.1.2 Product Picture and Specifications
  8.1.3 Abbott Diagnostics 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.1.4 Abbott Diagnostics 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.2 Becton, Dickinson and Company
  8.2.1 Company Profile
  8.2.2 Product Picture and Specifications
  8.2.3 Becton, Dickinson and Company 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.2.4 Becton, Dickinson and Company 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.3 QIAGEN
  8.3.1 Company Profile
  8.3.2 Product Picture and Specifications
  8.3.3 QIAGEN 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.3.4 QIAGEN 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.4 Roche Diagnostics
  8.4.1 Company Profile
  8.4.2 Product Picture and Specifications
  8.4.3 Roche Diagnostics 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.4.4 Roche Diagnostics 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.5 Agendia
  8.5.1 Company Profile
  8.5.2 Product Picture and Specifications
  8.5.3 Agendia 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.5.4 Agendia 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.6 Angsana Molecular and Diagnostics
  8.6.1 Company Profile
  8.6.2 Product Picture and Specifications
  8.6.3 Angsana Molecular and Diagnostics 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.6.4 Angsana Molecular and Diagnostics 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.7 Asuragen
  8.7.1 Company Profile
  8.7.2 Product Picture and Specifications
  8.7.3 Asuragen 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.7.4 Asuragen 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.8 Autogenomics
  8.8.1 Company Profile
  8.8.2 Product Picture and Specifications
  8.8.3 Autogenomics 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.8.4 Autogenomics 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.9 Beckman Coulter
  8.9.1 Company Profile
  8.9.2 Product Picture and Specifications
  8.9.3 Beckman Coulter 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.9.4 Beckman Coulter 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.10 bioMerieux
  8.10.1 Company Profile
  8.10.2 Product Picture and Specifications
  8.10.3 bioMerieux 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.10.4 bioMerieux 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.11 bioTheranostics (Formerly AviaraDx)
  8.11.1 Company Profile
  8.11.2 Product Picture and Specifications
  8.11.3 bioTheranostics (Formerly AviaraDx) 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.11.4 bioTheranostics (Formerly AviaraDx) 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.12 Cangen Biotechnologies
  8.12.1 Company Profile
  8.12.2 Product Picture and Specifications
  8.12.3 Cangen Biotechnologies 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.12.4 Cangen Biotechnologies 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.13 Cepheid
  8.13.1 Company Profile
  8.13.2 Product Picture and Specifications
  8.13.3 Cepheid 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.13.4 Cepheid 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.14 Diagnocure
  8.14.1 Company Profile
  8.14.2 Product Picture and Specifications
  8.14.3 Diagnocure 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.14.4 Diagnocure 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.15 Epigenomics
  8.15.1 Company Profile
  8.15.2 Product Picture and Specifications
  8.15.3 Epigenomics 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.15.4 Epigenomics 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.16 Eragen
  8.16.1 Company Profile
  8.16.2 Product Picture and Specifications
  8.16.3 Eragen 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.16.4 Eragen 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.17 EXACT Sciences
  8.17.1 Company Profile
  8.17.2 Product Picture and Specifications
  8.17.3 EXACT Sciences 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.17.4 EXACT Sciences 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.18 Exiqon
  8.18.1 Company Profile
  8.18.2 Product Picture and Specifications
  8.18.3 Exiqon 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.18.4 Exiqon 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.19 GeneNews
  8.19.1 Company Profile
  8.19.2 Product Picture and Specifications
  8.19.3 GeneNews 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.19.4 GeneNews 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.20 Genera Biosystems
  8.20.1 Company Profile
  8.20.2 Product Picture and Specifications
  8.20.3 Genera Biosystems 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.20.4 Genera Biosystems 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.21 Genomic Health
  8.21.1 Company Profile
  8.21.2 Product Picture and Specifications
  8.21.3 Genomic Health 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.21.4 Genomic Health 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.22 Genomix Biotech
  8.22.1 Company Profile
  8.22.2 Product Picture and Specifications
  8.22.3 Genomix Biotech 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.22.4 Genomix Biotech 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.23 Zhejiang Di'an Diagnostics Technology
  8.23.1 Company Profile
  8.23.2 Product Picture and Specifications
  8.23.3 Zhejiang Di'an Diagnostics Technology 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.23.4 Zhejiang Di'an Diagnostics Technology 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.24 Guangzhou Kingmed
  8.24.1 Company Profile
  8.24.2 Product Picture and Specifications
  8.24.3 Guangzhou Kingmed 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.24.4 Guangzhou Kingmed 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis
8.25 BGI-Shenzhen
  8.25.1 Company Profile
  8.25.2 Product Picture and Specifications
  8.25.3 BGI-Shenzhen 2015 Oncology Molecular Diagnostics Sales, Ex-factory Price, Revenue, Gross Margin Analysis
  8.25.4 BGI-Shenzhen 2015 Oncology Molecular Diagnostics Business Region Distribution Analysis

9 DEVELOPMENT TREND OF ANALYSIS OF MARKET

9.1 Global Market Trend Analysis
  9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
  9.1.2 Global 2016-2021 Sales Price Forecast
  9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
  9.2.1 USA 2016-2021 Oncology Molecular Diagnostics Consumption Forecast
  9.2.2 China 2016-2021 Oncology Molecular Diagnostics Consumption Forecast
  9.2.3 Japan 2016-2021 Oncology Molecular Diagnostics Consumption Forecast
  9.2.4 Germany 2016-2021 Oncology Molecular Diagnostics Consumption Forecast
  9.2.5 Canada 2016-2021 Oncology Molecular Diagnostics Consumption Forecast
  9.2.6 Russia 2016-2021 Oncology Molecular Diagnostics Consumption Forecast
  9.2.7 UK 2016-2021 Oncology Molecular Diagnostics Consumption Forecast
  9.2.8 India 2016-2021 Oncology Molecular Diagnostics Consumption Forecast
  9.2.9 Brazil 2016-2021 Oncology Molecular Diagnostics Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)

10 ONCOLOGY MOLECULAR DIAGNOSTICS MARKETING MODEL ANALYSIS

10.1 Oncology Molecular Diagnostics Regional Marketing Model Analysis
10.2 Oncology Molecular Diagnostics International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Oncology Molecular Diagnostics by Regions
10.4 Oncology Molecular Diagnostics Supply Chain Analysis

11 CONSUMERS ANALYSIS OF ONCOLOGY MOLECULAR DIAGNOSTICS

11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis

12 NEW PROJECT INVESTMENT FEASIBILITY ANALYSIS OF ONCOLOGY MOLECULAR DIAGNOSTICS

12.1 New Project SWOT Analysis of Oncology Molecular Diagnostics
12.2 New Project Investment Feasibility Analysis of Oncology Molecular Diagnostics

13 CONCLUSION OF THE GLOBAL ONCOLOGY MOLECULAR DIAGNOSTICS MARKET PROFESSIONAL SURVEY REPORT 2016